These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32088247)

  • 1. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM; Yu Y; Jiang J
    Pharmacol Ther; 2020 May; 209():107504. PubMed ID: 32088247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J; Yu Y; Kinjo ER; Du Y; Nguyen HP; Dingledine R
    Neuropharmacology; 2019 May; 149():149-160. PubMed ID: 30763657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
    Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
    Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
    Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J; Quan Y; Ganesh T; Pouliot WA; Dudek FE; Dingledine R
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3591-6. PubMed ID: 23401547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
    Rojas A; Ganesh T; Manji Z; O'neill T; Dingledine R
    Neuropharmacology; 2016 Nov; 110(Pt A):419-430. PubMed ID: 27477533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective.
    Yasmen N; Sluter MN; Li L; Yu Y; Jiang J
    Mol Brain; 2023 Jan; 16(1):14. PubMed ID: 36694204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
    J Neurosci; 2021 Feb; 41(5):1105-1117. PubMed ID: 33293358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.
    Santos AC; Temp FR; Marafiga JR; Pillat MM; Hessel AT; Ribeiro LR; Miyazato LG; Oliveira MS; Mello CF
    Epilepsy Behav; 2017 Aug; 73():180-188. PubMed ID: 28645087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits.
    Varvel NH; Amaradhi R; Espinosa-Garcia C; Duddy S; Franklin R; Banik A; Alemán-Ruiz C; Blackmer-Raynolds L; Wang W; Honore T; Ganesh T; Dingledine R
    Neuropharmacology; 2023 Feb; 224():109356. PubMed ID: 36460083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
    Kang X; Qiu J; Li Q; Bell KA; Du Y; Jung DW; Lee JY; Hao J; Jiang J
    Sci Rep; 2017 Aug; 7(1):9459. PubMed ID: 28842681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
    FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
    Yu Y; Li L; Nguyen DT; Mustafa SM; Moore BM; Jiang J
    Mol Neurobiol; 2020 Jun; 57(6):2830-2845. PubMed ID: 32378121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
    Rojas A; Ganesh T; Wang W; Wang J; Dingledine R
    Neurobiol Dis; 2020 Jan; 133():104399. PubMed ID: 30818067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
    FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of convulsive status epilepticus.
    Sánchez Fernández I; Goodkin HP; Scott RC
    Seizure; 2019 May; 68():16-21. PubMed ID: 30170734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.